Germany - Drugs

Description

See description of procurement
This is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded in the open-house model are not subject to public procurement law due to the lack of a selection decision. The AOK Bavaria intends to conclude non-exclusive rebate agreements with all interested pharmaceutical companies for the active ingredient combination rotigotine, ATC N04BC09, in accordance with Section 130a (8) of the German Social Code, Book V. The AOK Bavaria offers all interested pharmaceutical companies that meet the eligibility requirements listed below to conclude identical and non-individually negotiable rebate agreements. The earliest possible start date of the contract is 01.04.2023, all contracts end on 31.03.2025. A conclusion of the contract is possible at any time during this period, but no later than 05.02.2025. The contracts can be terminated with a notice period of one month to the end of the month. In the event of the entry into force of a rebate contract concluded by nationwide or state-specific open procedure for drugs with the active ingredient that is the subject of the contract, the open-house agreements shall automatically cease to apply for the corresponding term. A contract is concluded with all interested pharmaceutical companies that prove their suitability by means of a completed and signed self-declaration of reliability.The pharmaceutical company must send the completed and signed contract (the representative authority of the signatory(ies) must be evident from the extract from the commercial register, otherwise a power of attorney must be submitted) together with the completed Annex 1 and Annex 2 in triplicate in the original as well as the completed and signed self-declaration of reliability in triplicate to the following address:AOK Bayern - Die GesundheitskasseVergabestelle SGB VZE25open-house RabattverträgeCarl-Wery-Str. 2881739 MünchenIf complete and correct documents are received by the 5th of each month, the contract will start on the following first of the month, otherwise on the following first of the month after next. Sending the complete, completed and signed documents in advance by fax (089/62730650151) or as a scan to the e-mail address vergabestelle1@by.aok.de will meet the deadline if the complete and correct original documents are received in paper form by the 10th of the month by AOK Bayern, Vergabestelle.Interested pharmaceutical companies can apply for the activation of the contract and the self-declaration of reliability in the project room for the open house procedure on the portal www.dtvp.de. The application will be processed by the AOK Bayern, Vergabestelle. A link to the portal is included in this announcement.Only pharmaceutical companies are eligible as potential contractors. The documents of the open house procedure will only be released to pharmaceutical companies and are to be treated strictly confidential. The confidential treatment of the documents is confirmed by the companies' application for activation.

Opportunity closing date

05 February 2025

Value of contract

£0-100k